404 related articles for article (PubMed ID: 16729312)
1. Host cell responses induced by hepatitis C virus binding.
Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
4. Effect of hepatitis C virus core shadow protein expressed in human hepatoma cell line on human gene expression profiles.
Dou J; Liu P; Wang J; Zhang X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1794-800. PubMed ID: 17074016
[TBL] [Abstract][Full Text] [Related]
5. In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs.
Wunschmann S; Muller HM; Stipp CS; Hemler ME; Stapleton JT
J Infect Dis; 2006 Oct; 194(8):1058-67. PubMed ID: 16991080
[TBL] [Abstract][Full Text] [Related]
6. cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells.
Abe K; Ikeda M; Dansako H; Naka K; Shimotohno K; Kato N
Virus Res; 2005 Jan; 107(1):73-81. PubMed ID: 15567036
[TBL] [Abstract][Full Text] [Related]
7. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
[TBL] [Abstract][Full Text] [Related]
8. Impact of HIV on host-virus interactions during early hepatitis C virus infection.
Danta M; Semmo N; Fabris P; Brown D; Pybus OG; Sabin CA; Bhagani S; Emery VC; Dusheiko GM; Klenerman P
J Infect Dis; 2008 Jun; 197(11):1558-66. PubMed ID: 18419344
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of liver cell lines expressing entire or parts of hepatitis C virus open reading frame.
Aizaki H; Harada T; Otsuka M; Seki N; Matsuda M; Li YW; Kawakami H; Matsuura Y; Miyamura T; Suzuki T
Hepatology; 2002 Dec; 36(6):1431-8. PubMed ID: 12447869
[TBL] [Abstract][Full Text] [Related]
10. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
11. Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.
Xiang J; Wünschmann S; George SL; Klinzman D; Schmidt WN; LaBrecque DR; Stapleton JT
J Med Virol; 2002 Dec; 68(4):537-43. PubMed ID: 12376962
[TBL] [Abstract][Full Text] [Related]
12. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.
Steinmann D; Barth H; Gissler B; Schürmann P; Adah MI; Gerlach JT; Pape GR; Depla E; Jacobs D; Maertens G; Patel AH; Inchauspé G; Liang TJ; Blum HE; Baumert TF
J Virol; 2004 Sep; 78(17):9030-40. PubMed ID: 15308699
[TBL] [Abstract][Full Text] [Related]
14. Evidence for cellular uptake of recombinant hepatitis C virus non-enveloped capsid-like particles.
Tsitoura P; Georgopoulou U; Pêtres S; Varaklioti A; Karafoulidou A; Vagena D; Politis C; Mavromara P
FEBS Lett; 2007 Aug; 581(21):4049-57. PubMed ID: 17678898
[TBL] [Abstract][Full Text] [Related]
15. Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.
Sarobe P; Lasarte JJ; García N; Civeira MP; Borrás-Cuesta F; Prieto J
J Viral Hepat; 2006 Jan; 13(1):47-55. PubMed ID: 16364082
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus (HCV): a review of immunological aspects.
Irshad M; Khushboo I; Singh S; Singh S
Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
[TBL] [Abstract][Full Text] [Related]
17. Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene.
Sominskaya I; Alekseeva E; Skrastina D; Mokhonov V; Starodubova E; Jansons J; Levi M; Prilipov A; Kozlovska T; Smirnov V; Pumpens P; Isaguliants MG
Mol Immunol; 2006 May; 43(12):1941-52. PubMed ID: 16442623
[TBL] [Abstract][Full Text] [Related]
18. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes.
Nguyen H; Sankaran S; Dandekar S
Virology; 2006 Oct; 354(1):58-68. PubMed ID: 16876223
[TBL] [Abstract][Full Text] [Related]
20. Visualizing hepatitis C virus infections in human liver by two-photon microscopy.
Liang Y; Shilagard T; Xiao SY; Snyder N; Lau D; Cicalese L; Weiss H; Vargas G; Lemon SM
Gastroenterology; 2009 Oct; 137(4):1448-58. PubMed ID: 19632233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
